Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ECYT

Endocyte (ECYT) Stock Price, News & Analysis

Endocyte logo

About Endocyte Stock (NASDAQ:ECYT)

Advanced Chart

Key Stats

Today's Range
$23.99
$23.99
50-Day Range
N/A
52-Week Range
$2.81
$24.00
Volume
N/A
Average Volume
2.12 million shs
Market Capitalization
$1.97 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ECYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endocyte and its competitors with MarketBeat's FREE daily newsletter.

ECYT Stock News Headlines

Telix Pharmaceuticals Ltd (TLX)
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

ECYT Stock Analysis - Frequently Asked Questions

Endocyte, Inc. (NASDAQ:ECYT) issued its quarterly earnings data on Wednesday, November, 7th. The biopharmaceutical company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.01. The biopharmaceutical company had revenue of $0.09 million for the quarter, compared to the consensus estimate of $0.02 million. Endocyte had a negative net margin of 32,296.09% and a negative trailing twelve-month return on equity of 21.19%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Endocyte investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), Netflix (NFLX) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/07/2018
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ECYT
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.06 million
Net Margins
-32,296.09%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$70 thousand
Price / Sales
28,133.42
Price / Cash Flow
N/A
Book Value
$1.99 per share
Price / Book
12.06

Miscellaneous

Free Float
N/A
Market Cap
$1.97 billion
Optionable
Optionable
Beta
-0.01
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ECYT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners